21st week of 2015 patent applcation highlights part 48 |
Patent application number | Title | Published |
20150140090 | ANTI-INFLAMMATORY COMPOUNDS IN COMBINATION WITH HYDROGEN FOR THE TREATMENT OF INFLAMMATION - A composition for treating inflammation and pain, including a hydrogen-generating compound in an amount that increases the amount of hydrogen in an individual and has an anti-inflammatory effect. A composition for treating inflammation and pain, including synergistically effective amounts of pregabalin and lactulose. A method of treating inflammation and pain, by administering a composition comprising a hydrogen-generating compound to an individual in an amount that increases the amount of hydrogen in the individual and has an anti-inflammatory effect. | 2015-05-21 |
20150140091 | SOLID DISPERSION COMPRISING A HIGHLY SUBSTITUTED HYDROXYALKYL METHYLCELLULOSE - A solid dispersion comprising at least one active ingredient in at least one hydroxyalkyl methylcellulose having a DS of from 1.0 to 2.7 and an MS of from 0.40 to 1.30, wherein DS is the degree of substitution of methoxyl groups and MS is the molar substitution of hydroxyalkoxyl groups, can be produced by extrusion or spray-drying. | 2015-05-21 |
20150140092 | COATED DRUG DELIVERY FORMULATIONS - The invention relates generally to methods of making formulations for delivering biological agents to a patient. In one aspect, proliposomal drug-delivery systems for medicaments are provided. In another aspect, coated proliposomal formulations for poorly water soluble drugs, and methods for making the same, are provided. Certain embodiments of the present invention provide enhanced stability and bioavailability for pharmaceutical formulations. | 2015-05-21 |
20150140093 | NANOCLUSTERS COMPOSITIONS AND METHODS - Compositions, methods of making, and methods of using nanoclusters in which the nanoclusters comprise a plurality of nanoparticles having a core of nanoparticles arranged such that the surfaces of the nanoparticles contact adjacent nanoparticles, the nanoparticles comprise an active ingredient, and the nanocluster has a mass median aerodynamic diameter of from about 0.25 μm to about 20 μm. | 2015-05-21 |
20150140094 | PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID AND ADMINISTRATION THEREOF - A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient. | 2015-05-21 |
20150140095 | ONCE-A-DAY OXYCODONE FORMULATIONS - The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C | 2015-05-21 |
20150140096 | COMPOSITION AND METHOD OF PREPARATION OF BONE ALLOGRAFT FROM ENDOSTEAL PORTION OF BONE AND ISOLATED BONE PERIOSTEUM - Particulate bone and structural bone, more specifically decalcified bone from endosteum having osteoinductive capacity and methods for their isolation and production are provided, more specifically, decalcified bone preparations derived from endosteal layer of bone are provided. Compositions formulated with material from endosteal layer of bone are provided along with preparation and methods of using decalcified endosteal compositions are disclosed. Endosteum is avascular and areolar in distinction to bone marrow which fills the canal. Because of its structure and anatomic position, endosteum is difficult to isolate and recognize, and therefore not regarded as an important constituent of allograft materials. One embodiment of the present invention allows for recognition and isolation of endosteum. | 2015-05-21 |
20150140097 | CRYSTALLINE MICROSPHERES AND THE PROCESS FOR MANUFACTURING THE SAME - The present invention relates to microspheres and compositions comprising a plurality of microspheres, wherein the microspheres are perfectly spherical and have a moisture content less than 1%, and the method of manufacturing the same. The present invention is useful in the manufacture of sustained and modified release active pharmaceutical ingredient (API) microspheres, as a free flowing excipient for mini-tablets and in the manufacture of API dispersions. | 2015-05-21 |
20150140098 | ANIMAL FEED COMPRISING GRAIN AND AGARICUS BLAZEI EXTRACT AND USE OF THE FEED MATERIAL - The invention relates to the use of feed material comprising grain and | 2015-05-21 |
20150140099 | NOVEL DOSAGE FORM AND FORMULATION OF ABEDITEROL - A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier, providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base. | 2015-05-21 |
20150140100 | MEDICAL DEVICE FOR TREATMENT OF WOUNDS - The present invention describes a medical device comprising a set of particles of titanium oxide, wherein at least a substantial amount of the particles are of micrometer—millimeter size, and wherein at least 10 wt % of the titanium oxide is in the amorphous form. | 2015-05-21 |
20150140101 | SOLID ORAL COMPOSITIONS OF SILODOSIN - The present disclosure relates to solid oral compositions of silodosin or its pharmaceutically acceptable salt thereof. More particularly capsule compositions of silodosin with one or more pharmaceutically acceptable excipients and process for their preparation. | 2015-05-21 |
20150140102 | METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT - The present invention pertains to a method for producing a medicinal product comprising a biologically active protein comprising the steps of providing an aqueous composition comprising a solvent, the biologically active protein and between 20% w/w and 60% w/w of a non-polymeric sugar, freezing the composition, thereby forming at least one frozen body comprising the solvent in frozen form, putting the frozen body in a drying apparatus while being carried by a support, the support comprising one or more restraining elements that define one or more boundaries of the support, wherein at most 30% of the surface of the body is contiguous with the one or more restraining elements, reducing the pressure in the drying apparatus below atmospheric pressure, providing heat to the body in order to sublimate the frozen solvent of the body and obtain a dried body. The invention also pertains to a product obtainable by this method. | 2015-05-21 |
20150140103 | VACCINE - The present invention relates to a nucleic acid for vaccine that has undergone codon optimization for expression in | 2015-05-21 |
20150140104 | THERAPEUTIC POLYMERIC NANOPARTICLES AND METHODS OF MAKING AND USING SAME - Described herein are polymeric nanoparticles that include a therapeutic agent which is 2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide (also known as AZD1152 hqpa) or a pharmaceutically acceptable salt thereof, and methods of making and using such therapeutic nanoparticles. | 2015-05-21 |
20150140105 | FREE FLOWING, FROZEN COMPOSITIONS COMPRISING A THERAPEUTIC AGENT - Disclosed are frozen, free-flowing compositions that may contain one or more therapeutic agents and at least one flavoring agent, such compositions being useful for the delivery of an effective amount of a therapeutic agent to an individual in need thereof. Also disclosed are methods of making and using such compositions. | 2015-05-21 |
20150140106 | OCULAR NANOFORMULATION AND METHOD OF USE IN ANGIOGENESIS-MEDIATED DISORDERS - An ophthalmic formulation that includes nanoparticles. Each nanoparticle includes a shell which encapsulates sulfated non-anticoagulant heparin (SNACH), with or without hydrophobic anti-angiogenesis Tyrosine Kinase inhibitors. The SNACH is ionically or covalently bonded to the shell. The shell includes a polymer selected from the group consisting of poly (lactic-co-glycolic acid) (PLGA), chitosan, chitosan-alginate, and NIPAAM-APMAH-AA, wherein NIPAAM is N-isopropyl acrylamide, APMAH is N-3-aminopropylmethacrylamide hydrochloride, and AA is acrylic acid. A method for treating an eye disease of a subject includes: administering to an eye of the subject a therapeutically effective amount of the ophthalmic formulation for treating the eye disease. The eye disease involves an ocular angiogenesis-mediated disorder. | 2015-05-21 |
20150140107 | DELIVERY OF HYDROPHOBIC ACTIVE AGENT PARTICLES - Embodiments of the invention include drug delivery coatings and devices including the same. In an embodiment, the invention includes a drug delivery coating including a polymeric layer. The polymeric layer can include a hydrophilic outer surface. The coating can also include a matrix contacting the hydrophilic outer surface. The matrix can include a particulate hydrophobic therapeutic agent and a cationic agent. The polymeric layer can further include a hydrophilic polymer having pendent photoreactive groups and a photo-crosslinker including two aryl ketone functionalities. Other embodiments are also included herein. | 2015-05-21 |
20150140108 | LIPIDATED GLYCOSAMINOGLYCAN PARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS - There are provided compositions comprising lipidated glycosaminoglycan particles, methods for their preparation and uses thereof for the efficient in-vivo and in-vitro delivery of nucleic acids, such as, siRNA molecules. | 2015-05-21 |
20150140109 | DOCETAXEL-BASED PROLONGED-RELEASE CANCER TREATMENT DRUG - The present invention relates to the field of pharmacology and medicine, specifically to a new generation of anticancer drugs with the cytostatic action based on docetaxel. In the drug composition of the invention docetaxel is included in biodigestible stable nanoparticles. The nanoparticles comprise of docetaxel, PLGA, serum albumin and D-mannitol The developed drug is proposed to be manufactured as enterosoluble tablets, capsules granules, powder, or in any other peroral form. | 2015-05-21 |
20150140110 | COMPOSITIONS OF JASMONATE COMPOUNDS AND METHODS OF USE - The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-κB-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions. | 2015-05-21 |
20150140111 | PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF - The invention relates to effervescent pharmaceutical dosage forms including cefdinir as the active agent, and their preparation. The invention also relates to effervescent formulations including ceftibuten and/or its pharmaceutically acceptable salts, hydrates, solvates, esters, amorphous and crystal forms and/or a combination thereof. The invention also relates to pharmaceutical compositions including (Z)-3-Carboxymethyl-7-(2-(2-furyl)-2-methoxyiminoacetylamino)-3-sefem-4-carboxylic acid which is named cefuroxime axetil or any pharmaceutically acceptable derivative thereof, and the use of these compositions in the treatment of bacterial infections. Lastly, the invention relates to pharmaceutical formulations including a third generation cephalosporin together with clavulanic acid and/or derivatives thereof as the active agents. | 2015-05-21 |
20150140112 | COMPOSITION COMPRISING EXTRACT OF MIXTURE OF UNDARIA PINNATIFIDA SPOROPHYLLS AND ASCIDIAN SHELLS FOR TREATING ATOPIC DERMATITIS - The present invention relates to a composition comprising an extract of a mixture of | 2015-05-21 |
20150140113 | GELLING AGENT-BASED DOSAGE FORM - The present invention generally relates to dosage forms for oral administration including one or more gelling agents. In particular, the present invention is directed to gelling agent-based dosage forms that are easily administered and taken, or swallowed. The present invention is also directed to gelling agent-based dosage forms that exhibit relatively low syneresis, are thermally stable, exhibit substantially constant active ingredient concentration, and/or exhibit one or more advantageous rheological properties. In particular, the present invention is directed to such gels containing one or more omega-3 fatty acids. The gelling agent-based dosage forms of the present invention are suitable for administration of a relatively large dose of active ingredient. The gelling agent-based dosage forms of the present invention are also suitable for administration of multiple active ingredients. Dosage forms of the present invention also provide tamper resistance and, thus, prevent recovery or diversion of active ingredients contained therein. The gelling agent-based dosage forms are also suitable for use as gastro-retentive and sustained release dosage forms. | 2015-05-21 |
20150140114 | SKIN TREATMENT PROTOCOL UTILIZING AMNIOTIC SOLUTION - A skin treatment method, including: performing a skin treatment procedure on the skin of a patient, wherein the skin treatment procedure includes one of a chemical peel procedure, a dermabrasion procedure, a micro-needling procedure, and a laser procedure; and subsequently, applying a preparation including one or more of amniotic fluid and amniotic membrane material to the treated skin of the patient to promote healing and collagen rejuvenation, wherein the preparation including the one or more of amniotic fluid and amniotic membrane material is prepared from one or more of amniotic fluid, a concentrated amniotic membrane solution, and an amniotic membrane powder. The preparation comprising the one or more of amniotic fluid and amniotic membrane material also includes sterile water or saline. The treated skin of the patent preferably includes one or more of the skin of the face and the skin of the neck. | 2015-05-21 |
20150140115 | ORIENTAL MEDICINE COMPOSITIONS MARKED AS SEC 22 AND SEC 33 FOR IMPROVING CHILDREN'S UNDERWEIGHT, LOW GROWTH AND DEPRESSED RESPIRATORY ORGAN - The present invention relates to oriental medicine compositions marked as SEC 22 and SEC 33 for improving digestive functions and respiratory functions for improving children's underweight, low growth and depressed respiratory organ, an oriental medicine derived therefrom, and methods of preparing them. According to an example of the present invention, the oriental medicine composition containing broiled fruit of | 2015-05-21 |
20150140116 | BONE IMPLANT MATERIALS COMPRISING CROSS-LINKED BIOACTIVE HYDROGEL MATRICES - The present invention is directed to a stabilized cross-linked hydrogel matrix comprising a first high molecular weight component and a second high molecular weight component that are covalently linked, and at least one stabilizing or enhancing agent, wherein the first high molecular weight component and the second high molecular weight component are each selected from the group consisting of polyglycans and polypeptides. This stabilized hydrogel matrix may be prepared as bioactive gels, pastes, slurries, cell attachment scaffolds for implantable medical devices, and casting or binding materials suitable for the construction of medical devices. The intrinsic bioactivity of the hydrogel matrix makes it useful as a gel or paste in multiple applications, including as a cell attachment scaffold that promotes wound healing around an implanted device, as gels and pastes for induction of localized vasculogenesis, wound healing, tissue repair, and regeneration, as a wound adhesive, and for tissue bulking. | 2015-05-21 |
20150140117 | BIOACTIVATED BONE SUBSTITUTE MATERIAL - The present invention generally relates to the field of bone substitute materials, and particularly to a bone substitute material that is bioactivated. More specifically, the present invention relates to a particular agent comprising citrate, citric acid, monobasic sodium phosphate, dextrose, and adenine for use in improving or promoting osseointegration of a bone substitute material, to a bone substitute material provided with a coating of said particular agent, and to a kit for use in a method of installing a bone substitute material comprising a bone substitute material as well as citrate, citric acid, monobasic sodium phosphate, dextrose, and adenine. | 2015-05-21 |
20150140118 | Injectable Calcium-Phosphate Cement Releasing A Bone Resorption Inhibitor - The present invention relates to a macroporous, resorbable and injectable apatitic calcium-phosphate cement with a high compressive strength useful as bone cement and releasing a bone resorption inhibitor, preparation method and uses thereof. | 2015-05-21 |
20150140119 | METHOD FOR BONE TISSUE REGENERATION IN EXPERIMENTS - The invention relates to the treatment of different bone injuries, particularly fractures and fissure fractures, and can be used in medical and veterinary therapy and surgery. In order to reduce the time taken for bone tissue to regenerate at the site of damage or a defect and to reduce the time taken for the normal physiological functioning of an injured bone o be restored, a method is used for regenerating bone tissue by fixing fragments of the damaged bone with a plaster cast or a bandage made of a polymer material and introducing into the fracture zone an aqueous solution containing 1-hydroxyethylidene diphosphonic acid in an amount of (1.80-2.06) g/l, anhydrous calcium chloride in an amount of (1.44-2.22) g/l, gadolinium (III) nitrate hexahydrate in an amount of (0.3-0.40) g/l and dysprosium (III) chloride hexahydrate in an amount of (0.038-0.076) g/l, with a pH of (7.3-7.8), wherein, prior to being introduced into the fracture zone, the above solution is brought to a temperature of (30-100)° C., is held at this temperature for (1-48) hours and is then cooled to room temperature. As a result, there is a significant (20-25%) reduction in the time taken for bone tissue to regenerate at the injury site, irrespective of the type of animal which has sustained the injury. The above-mentioned solution for injection has low toxicity and good storage properties and can be kept for an extended period of time without loss of activity. | 2015-05-21 |
20150140120 | STABILIZED APTAMERS TO PLATELET DERIVED GROWTH FACTOR AND THEIR USE AS ONCOLOGY THERAPEUTICS - Materials and methods are provided for producing and using aptamers useful as oncology therapeutics capable of binding to PDGF, PDGF isoforms, PDGF receptor, VEGF, and VEGF receptor or any combination thereof with great affinity and specificity. The compositions of the present invention are particularly useful in solid tumor therapy and can be used one or in combination with known cytotoxic agents for the treatment of solid tumors. Also disclosed are aptarmers having one or more CpG motifs embedded therein or appended thereto. | 2015-05-21 |
20150140121 | Compositions and Methods for Tight Junction Modulation - Compositions and methods for modifying the composition of tight junction complexes and/or improving epithelial barrier function are disclosed. | 2015-05-21 |
20150140122 | METHODS FOR DETECTING INACTIVATION OF THE HOMOLOGOUS RECOMBINATION PATHWAY (BRCA1/2) IN HUMAN TUMORS - The invention relates to methods for detecting inactivation of the DNA Homologous Recombination pathway in a patient, and in particular for detecting BRCA1 inactivation. | 2015-05-21 |
20150140123 | Protein expression analyses for identifying genotoxic compounds - The invention relates to a method for screening compounds with (pro-)genotoxic activity by providing a system being capable of expressing a panel of defined proteins, incubating at least a portion of the system with compounds to be screened, and comparing the expression of the proteins in the system with the protein expression in a control system, thereby detecting the (pro-)genotoxic activity. Another object of the invention concerns a method for monitoring the likelihood of developing a physiological and/or pathological condition, which is caused, mediated and/or propagated by the genetic deregulation of proliferation, differentiation and/or damage repair, in response to a compound administered to a mammal in need of such treatment by determining an expression level of defined proteins in a biological sample withdrawn from the mammal. The invention also relates to a kit for screening compounds with (pro-)genotoxic activity comprising antibodies that specifically bind to marker proteins. | 2015-05-21 |
20150140124 | METHOD OF DIAGNOSING, TREATING AND DETERMINING PROGRESSION AND SURVIVAL OF CANCER CELLS USING BCL-2 ANTAGONIST OF CELL DEATH (BAD) PATHWAY GENE SIGNATURE - The present invention relates to the BAD pathway's influence on development, progression, chemo-sensitivity, and overall survival for multiple human cancers and its potential as a therapeutic target to increase chemo-sensitivity. BAD pathway expression was associated with the development and/or progression of breast, colon, and endometrial cancers, relapse-free survival from breast cancer, and overall survival from ovarian, colon, and brain cancers. Expression was also associated with in vitro sensitivity to a range of cytotoxic agents. pBAD levels were higher in cancer versus immortalized normal cells and chemo-resistant versus—sensitive cancer cells and associated with increased cell proliferation. | 2015-05-21 |
20150140125 | SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS - Synergistic cancer therapy drug combinations include therapeutically effective amounts of at least one chemotherapeutic drug or agent with a fortified decoction dosage form comprising from about 10 mg to about 6,000 mg each of β-sitosterol, isovanillin, and linolenic acid. The decoction dosage preferably includes plant extract(s) of the genus | 2015-05-21 |
20150140126 | REPELLING AGENT, BITE REPELLING AGENT AND ARTHROPOD-BORNE DISEASE PREVENTIVE AGENT - A measure that can readily prevent arthropod-borne diseases such as malaria that are contracted by 3 to 5 hundred million people worldwide yearly and that cause death of as many as 1.5 to 2.7 million people. By spraying in advance on the skin an arthropod-borne disease preventive agent or the like including chlorine dioxide as an effective component thereof, it is possible to provide repelling effect against arthropods such as infected mosquitoes that bear malaria protozoa and also to prevent biting of the skin by the arthropod, thus reducing contraction of the arthropod-borne diseases. | 2015-05-21 |
20150140127 | METHOD FOR DETECTING INJURY TO THE BRAIN - Provided is a method for detecting injury to the brain comprising: a) determining the level of a tight junction (TJ) protein in exosomes isolated from a test sample from a subject, wherein the TJ protein is occludin, claudin-3, claudin-5, claudin-12, ZO-1, ZO-2, ZO-3, JAM-A, JAM-B or JAM-C, or any combination thereof; b) comparing the level of the TJ protein in the test sample to the level of the TJ protein in a control sample, wherein an elevated level of the TJ protein in the test sample relative to the level of the TJ protein in the control sample indicates that the subject has an injury to the brain. | 2015-05-21 |
20150140128 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES - Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided. | 2015-05-21 |
20150140129 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES - Compositions comprising electro-activated aqueous solutions and methods for the prevention and treatment of dysfunctional cardiovascular conditions are provided. | 2015-05-21 |
20150140130 | TREATMENT OF NEUROLOGICAL DISORDERS - A treatment of a neurological disorder, including hypoxia, oxygen-glucose deprivation and acute brain trauma in a subject involves administering an effective amount of selenate or a pharmaceutically acceptable salt thereof to the subject. The treatment prevents incurring a symptom, holds in check a symptom or treats an existing symptom of the neurological disorder. | 2015-05-21 |
20150140131 | Therapeutic Composition And Use - The use of liquid formulations in the preparation of a medicament for the prevention and treatment of oral, gastric and digestive infections and in particular for the prevention of ventilator associated pneumonia as well as liquid enteral and parenteral tube feeding compositions. The feeding compositions are suitable for use in the prevention of ventilator associated pneumonia. | 2015-05-21 |
20150140132 | MONOTERPENE GLYCOSYLTRANSFERASE ORIGINATING FROM HOP AND METHOD FOR USING SAME - The object of the present invention is to provide | 2015-05-21 |
20150140133 | IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM - A system is described for long-term controlled release delivery of a drug or a therapeutic agent. According to the invention, one or more drugs or therapeutic agents contained in microspheres are mixed with a temperature sensitive hydrogel which is then introduced directly to the desired situs of the drug or therapeutic agent. The temperature sensitive hydrogel may also contain a drug or a therapeutic agent, for example, a pain relieving drug, for a short-term controlled release. The temperature sensitive hydrogel is in liquid state at room temperature, but upon injection, shortly becomes gelatinous. This system is particularly suitable for treatment of diseases, disorders, or conditions, for example, tumors, discogenic back pain, or arthritis, warranting localized administration of a drug or a therapeutic agent. In addition, the specification provides a method for production of a drug- or therapeutic agent-containing microspheres. | 2015-05-21 |
20150140134 | Natural cream pain reliever - The Natural Cream Pain Reliever is a 100% natural formula with coconut as the main component and a manufacturing process using refrigeration to extract the purist and most concentrated portion of the ingredients. | 2015-05-21 |
20150140135 | METHOD OF USING DIETARY SUPPLEMENTS COMPRISING CINNAMON EXTRACTS TO PROMOTE WEIGHT LOSS - A method for promoting weight loss and/or lowering blood glucose comprises an active material which may be cinnamon, an extract of cinnamon, or a derivative of a cinnamon extract. The active material may be utilized in combination with further active ingredients. | 2015-05-21 |
20150140136 | PESTICIDAL COMPOSITIONS AND METHODS FOR USING SAME - Pesticidal compositions containing plant essential oils, such as rosemary oil, wintergreen oil, etc., and methods for using same are disclosed. | 2015-05-21 |
20150140137 | COMBINED ALLERGY TREATMENT AND ANTI-DRYING COMPOSITIONS AND RELATED METHODS - Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition. The composition may further comprise an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition. The composition may be delivered into at least one of the human's nose, eyes, mouth, and throat. | 2015-05-21 |
20150140138 | Decubitus Treatment System - The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 MPS, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 MPS, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 MPS and water. | 2015-05-21 |
20150140139 | COMPOSITION FOR IMPROVING OR PROMOTING HAIR GROWTH CONTAINING, AS ACTIVE INGREDIENTS, PHOTOSENSITIZER IRRADIATED WITH LIGHT AND PEPTIDE, AND METHOD USING SAME - The present invention relates to a composition for improving or promoting hair growth, which contains, as an active ingredient, a photosensitizer-peptide conjugate, and to a method for screening for the hair growth promoter using the active ingredients. ALA, which is the photosensitizer of the present invention, is preferably activated by LED radiation, and more preferably activated by radiation having a long wavelength of 650 to 675 nm. The peptide of the present invention is a peptide in which 3 to 7 amino acid residues are incorporated (most preferably, glycine-histidine-lysine), and may cooperate with the photosensitizer to enable very superior hair growth improving or promoting effects using light radiation. Further, the composition of the present invention may exhibit further superior effects when natural extracts (for example, | 2015-05-21 |
20150140140 | FORMULATION OF DUAL CYCLOXYGENASE (COX) AND LIPOXYGENASE (LOX) INHIBITORS FOR MAMMAL SKIN CARE - The present invention provides a novel composition of matter comprised of a mixture of two specific classes of compounds—Free-B-Ring flavonoids and flavans—for use in the prevention and treatment of diseases and conditions associated with the skin. This composition of matter simultaneously inhibits cyclooxygenase (COX) and lipoxygenase (LOX) enzymatic activity in normal, aged and damaged dermal cells and tissues. This invention further provides a method for the prevention and treatment of diseases and conditions of the skin mediated by cyclooxygenase (COX) and lipoxygenase (LOX). The method for preventing and treating COX and LOX mediated diseases and conditions of the skin is comprised of topically administering to a host in need thereof a therapeutically effective amount of a composition comprising a mixture of Free-B-Ring flavonoids and flavans synthesized and/or isolated from a single plant or multiple plants, preferably in the | 2015-05-21 |
20150140141 | METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION - The present disclosure relates to methods for extraction of biomass. Biomass of most interest is that which contains biologically active, extracts suitable for the skin care market. The biomass of interest includes botanicals (plant extracts and bioferments thereof), algae (red, brown, green and red, including bioferments thereof), fungi and even animal extracts (insect, crustacean) origin. Further the use of said extracts in cosmetic preparations prepared by the disclosed method is envisioned. | 2015-05-21 |
20150140142 | MEDICINAL COMPOSITION OF EXTRACT OF SEED OF EMBLICA OFFICINALIS AND METHOD OF PREPARING THE SAME - A composition having an extract of seed of | 2015-05-21 |
20150140143 | NUTRIPROTECTIVE DIET - The present document describes a nutriprotective diet comprising a nutriprotective amount of a sugar plant syrup, a sugar plant syrup extract, a sugar plant extract, or combinations thereof The present document also describes a method of eliciting a nutriprotective effect in a subject, which comprises administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document also describes a method of treating a subject with a disorder, by administering a nutriprotective amount of a nutriprotective diet according to the present invention. Also, the present document describes a process for the extraction of polyphenolic compounds from maple syrup using adsorbent materials, and the extracts obtained therefrom. | 2015-05-21 |
20150140144 | AQUEOUS-LIPIDIC CAROTENOID-CONTAINING COMPOSITIONS - The invention provides a primary carotenoid-containing composition comprising an aqua-containing component, a lipid-containing component and a carotenoid-containing fiber material from plant origin with lowered content of aqua-soluble substances. The invention also provides oral compositions that comprise the primary composition in a foodstuff, in a food supplement or in a pharmaceutical preparation. | 2015-05-21 |
20150140145 | THREE-DIMENSIONAL PRINTER TOOL SYSTEMS - An extruder or other similar tool head of a three-dimensional printer is slidably mounted along a feedpath of build material so that the extruder can move into and out of contact with a build surface according to whether build material is being extruded. The extruder may be spring-biased against the forward feedpath so that the extruder remains above the build surface in the absence of applied forces, and then moves downward into a position for extrusion when build material is fed into the extruder. In another aspect, modular tool heads are disclosed that can be automatically coupled to and removed from the three-dimensional printer by a suitable robotics system. A tool crib may be provided to store multiple tool heads while not in use. | 2015-05-21 |
20150140146 | ELECTRO-OPTIC MIRROR ELEMENT AND PROCESS OF MAKING SAME - A system for filling a variable reflectance vehicular electro-optic element assembly (such as for a rearview mirror assembly) includes a front substrate, a rear substrate and a perimeter seal disposed between the front and rear substrates. The perimeter seal spaces the front and rear substrates apart and forms an interpane cavity therebetween. The perimeter seal has a gap between terminal ends of the perimeter seal to provide a fill port for the mirror reflective element assembly when the front and rear substrates are mated together. The fill port allows an electro-optic medium to flow therethrough during the filling process. During the filling process, the front and rear substrates are fixtured in a chamber with the fill port disposed at an upper portion of the front and rear substrates, with the filling process being one of (i) a gravity feed filling process and (ii) a pressurized filling process. | 2015-05-21 |
20150140147 | TWO-MOTOR MULTI-HEAD 3D PRINTER EXTRUSION SYSTEM - A 3D printing system having a rotating plate wherein at least two printing components are selectively attached to said rotating plate, and wherein said rotating plate is capable or rotating to selectively engage each said printing component to a drive motor which is capable of driving the printing component when engaged. | 2015-05-21 |
20150140148 | CONTROLLER FOR INJECTION MOLDING MACHINE - In a molding cycle, one process (intermediate process) is provided between an injection process and a packing process, and conditions for switching from the injection process to the intermediate process and switching from the intermediate process to the packing process are set individually. In the intermediate process, an injection pressure is detected and a target pressure is obtained based on the injection pressure. Pressure control in the intermediate process is performed based on the set target pressure. | 2015-05-21 |
20150140149 | High Throughput Imprint Based on Contact Line Motion Tracking Control - Systems for controlling velocity of a contact line and height profile between a template and a substrate during imprinting of polymerizable material are described. | 2015-05-21 |
20150140150 | THREE-DIMENSIONAL PRINTER TOOL SYSTEMS - An extruder or other similar tool head of a three-dimensional printer is slidably mounted along a feedpath of build material so that the extruder can move into and out of contact with a build surface according to whether build material is being extruded. The extruder may be spring-biased against the forward feedpath so that the extruder remains above the build surface in the absence of applied forces, and then moves downward into a position for extrusion when build material is fed into the extruder. In another aspect, modular tool heads are disclosed that can be automatically coupled to and removed from the three-dimensional printer by a suitable robotics system. A tool crib may be provided to store multiple tool heads while not in use. | 2015-05-21 |
20150140151 | THREE-DIMENSIONAL PRINTER TOOL SYSTEMS - An extruder or other similar tool head of a three-dimensional printer is slidably mounted along a feedpath of build material so that the extruder can move into and out of contact with a build surface according to whether build material is being extruded. The extruder may be spring-biased against the forward feedpath so that the extruder remains above the build surface in the absence of applied forces, and then moves downward into a position for extrusion when build material is fed into the extruder. In another aspect, modular tool heads are disclosed that can be automatically coupled to and removed from the three-dimensional printer by a suitable robotics system. A tool crib may be provided to store multiple tool heads while not in use. | 2015-05-21 |
20150140152 | THREE-DIMENSIONAL PRINTING APPARATUS - A three-dimensional printing apparatus including a tank filled with a liquid-state forming material, a platform disposed at the tank, a rotating shaft, a rotating arm, and at least one light source is provided. The rotating shaft is disposed under the tank or above the tank. The rotating arm connects to the rotating shaft such that the rotating arm is driven by the rotating shaft to rotate. The light source disposed on the rotating arm rotates along with the rotating arm and generates light projecting toward the forming material along with the part of the platform moving in the forming material, such that the forming material is solidified in layers and forms a three-dimensional object on the platform. | 2015-05-21 |
20150140153 | Inductively Heated Extruder Heater - One embodiment of a heated nozzle for extruding meltable material consists of an electrically conductive nozzle, comprised of an inlet, an outlet, and a passage connecting inlet and outlet. The nozzle fits into a hole or gap cut or formed through a loop of high permeability soft magnetic material such as ferrite or pressed iron powder. Electrically conductive wire is coiled around and through this magnetic loop to form a coil. A high-frequency alternating current is supplied to the coil, inducing a magnetic field in the magnetic core. The magnetic field, when passing through the electrically conductive nozzle, induces eddy currents that heat the nozzle to melt the material entering the inlet. Another embodiment consists of an electrically conductive nozzle, comprising inlets, outlets, and passages connecting inlets and outlets, fitted into a hole penetrating two faces of a hollow, high-permeability, soft magnetic core with a coil of electrically conductive wire wound in a coil around the nozzle, inside the hollow magnetic core. A high frequency alternating current passing through this coil induces eddy currents in the nozzle to heat materials entering the inlet or inlets and passing out the outlet or outlets. | 2015-05-21 |
20150140154 | MOLD BASE MATERIAL, PRODUCTION METHOD FOR MOLD BASE MATERIAL, MOLD PRODUCTION METHOD, AND MOLD - A mold base of an embodiment is a mold base for use in manufacture of a mold that has a porous alumina layer over its surface, including: a base; and an aluminum alloy layer provided on the base, wherein the aluminum alloy layer contains aluminum, a non-aluminum metal element, and nitrogen. The aluminum alloy layer of the mold base of an embodiment of the present invention has high specularity. | 2015-05-21 |
20150140155 | THREE-DIMENSIONAL MODELING HEAD AND THREE-DIMENSIONAL MODELING DEVICE - According to an embodiment, a three-dimensional modeling head includes a heat insulating member, a light emitter, a cylindrical member, and a light absorbing member. The heat insulating member has a sealed space therein with a curved wall surface that reflects light. The light emitter emits light and has at least a light emitting face provided in the sealed space. The cylindrical member is placed to extend through the heat insulating member via the sealed space and is long in a first direction in which thermoplastic resin is ejected. The light absorbing member adsorbs light and is provided in contact with at least part of the cylindrical member in the sealed space and in an area of the sealed space containing a focusing position on which at least part of light emitted by the light emitter and reflected by the wall surface is focused. | 2015-05-21 |
20150140156 | NON-DEFORMABLE PATTERNED TEMPLATE - A non-deformable patterned template includes a stable mesh, wherein the stable mesh is resistant to deformation; a polymer sheet with the stable mesh embedded therein, wherein the polymer sheet is formed using a liquid polymer adapted to receive the stable mesh, and wherein the liquid polymer is cured after the stable mesh has been placed within the liquid polymer; and a surface pattern on at least one face of the polymer sheet. | 2015-05-21 |
20150140157 | MOLD PLATE AND METHOD OF MOLDING GOLF BALL CORE - A mold for manufacturing hemispherical sections for a golf ball includes a mold plate and a movable insert. The mold plate includes a first surface. The movable insert includes a second surface. The moveable insert is connected to the mold plate. The first surface of the mold plate and the second surface of the movable insert may move relative to one another during molding of the hemispherical section for a golf ball. | 2015-05-21 |
20150140158 | THREE-DIMENSIONAL PRINTING SYSTEMS - Three-dimensional printing systems are disclosed that are reliable, accurate and easy to use. Leveling sub-systems including a leveler ramp for raising and lowering a measurement probe to determine and adjust the height of an extrusion head with respect to the build platform are disclosed. X-Y translation gantries and extrusion heads that are easy to use and assemble are also disclosed. | 2015-05-21 |
20150140159 | BLOW MOLD UNIT AND BLOW MOLDING MACHINE USING SAME - A blow mold unit including a blow mold including first and second blow cavity split molds and a plurality of raised bottom molds, first and second pressure receiving plates, a first fixing plate to which the first blow cavity split mold and the first pressure receiving plate are fixed, a second fixing plate to which the second blow cavity split mold and the second pressure receiving plate are fixed, a third fixing plate interposed between the first and second fixing plates and to which the plurality of raised bottom molds are fixed at a first surface thereof, a shaft portion extending vertically from a second surface of the third fixing plate, an elevation guide block fixed to one of the first and second fixing plates and elevation guiding the shaft portion, and an elevating rod extending vertically from the second surface. There is also a blow molding machine which includes the blow mold unit. | 2015-05-21 |
20150140160 | Stack Mold System - A stack mold system includes, a first mold section, a second mold section, a central mold section disposed between the first and second mold sections, the first mold section and the central mold section configured to translate along a longitudinal axis relative to the second mold section. The stack mold system includes a hydraulic assembly coupled to the first mold section, the second mold section, and the central mold section. The hydraulic assembly is configured to maintain substantially equal distances between opposed faces of the adjacent mold sections when the first mold section translates between a first position and a second position along the longitudinal axis and regardless of whether the mold sections are disposed in a closed or open state, or are in transition between the closed and open states. | 2015-05-21 |
20150140161 | METHODS OF IMPROVING TOLERANCE RELATED TO FEEDING IN AN INFANT, TODDLER, OR CHILD - Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component. | 2015-05-21 |
20150140162 | MICROWAVE RICE COOKING BOWL - A bowl is provided for rapid and repeatable high quality cooking of rice or other grains within a microwave. The bowl includes a reservoir with a floor and walls extending up from the floor to a rim. Handles are preferably provided extending laterally from the rim. A rice line is provided which is visible to a user and defines a height at which rice should be added for cooking within the bowl. A water line is provided above the rice line which defines an elevation to which water should be added for cooking of the rice. In one embodiment walls of the reservoir are tapered to accommodate boiling and frothing without boiling over and still maintaining a compact cooking space within the bowl. | 2015-05-21 |
20150140163 | COMPOSITIONS AND METHODS FOR COATING DRY PET FOOD KIBBLE - Compositions and methods are provided for evenly coating or glazing dry pet food kibbles for improved palatability without loss of crunchiness of the dry kibbles over an extended time period. The coating compositions comprise water and at least one of a gum or a modified starch. The coating composition can comprise an additional ingredient such as one or more of a flavor, a color, an emulsified or particulate meat, an emulsified or particulate fruit or vegetable, an antioxidant, a vitamin, a mineral, a non-replicating microorganism, a fiber or a prebiotic. In an embodiment, the coating composition can include dextrose and/or glycine. After mixing and retorting, the coating composition can be a viscous paste with a viscosity of 2500 to 4000 centipoises, preferably 3000 to 3500 centipoises, as measured at room temperature. | 2015-05-21 |
20150140164 | METHODS FOR MANAGING WEIGHT LOSS AND BODY MASS - The invention provides methods for promoting weight loss by an animal, promoting weight loss by an animal while preventing or minimizing loss of lean body mass by the animal, preventing a reduction in energy metabolism by an animal, reducing the risk of regaining weight by an animal after weight loss, and ameliorating undesirable animal behaviors associated with reduced caloric intake by intermittently feeding an animal a first diet containing calories that meet the animal's maintenance energy requirements and a second diet containing calories that do not meet the animal's maintenance energy requirements. In preferred embodiments, the described feeding pattern and diets are fed in conjunction with one or more weight loss agents. | 2015-05-21 |
20150140165 | USE OF POLYPEPTIDES HAVING PROTEASE ACTIVITY IN ANIMAL FEED AND DETERGENTS - The present invention relates to the use of isolated polypeptides having protease activity in animal feed and detergents. It also relates to the use of isolated nucleic acid sequences encoding the proteases in the recombinant production of isolated polypeptides having protease activity and isolated nucleic acid sequences encoding the proteases. The invention also relates to nucleic acid constructs, vectors, and host cells, including plant and animal cells, comprising the nucleic acid sequences, as well as methods for producing and using the proteases, particularly using the proteases in animal feed and detergents. | 2015-05-21 |
20150140166 | PROCESS FOR PREPARING A LIQUID FOOD PRODUCT ENRICHED WITH OLIGOSACCHARIDES AND WITH POLYSACCHARIDES - The subject matter of the invention is a process for preparing a liquid food product enriched with oligosaccharides and with polysaccharides starting from berries, in the absence of alcoholic fermentation in the presence of the berries, which comprises (a) heating the berries at a temperature ranging from 40° C. to 100° C., (b) placing the berries under vacuum at a pressure ranging from 10 | 2015-05-21 |
20150140167 | MICROENCAPSULATED BACTERIAL CONSORTIUM FOR THE DEGRADATION OF GLUTEN INTO SOURDOUGH AND METHOD FOR PRODUCING SAID SOURDOUGH - The present invention is related to a microencapsulated bacterial consortium for gluten degradation, which comprises: a) three different strains of commercially available lactic-acid bacteria; b) encapsulating agents; c) prebiotics; and d) trehalose; in combination with a proteolytic enzyme of bacterial origin and a proteolytic enzyme of fungal origin. Preferably, the microencapsulated bacterial consortium comprises: a) | 2015-05-21 |
20150140168 | Method of Baking - The present invention relates to the making of sponge cake, more particularly making of sponge cake using polypeptides having lysophospholipase activity. The invention also relates to compositions comprising polypeptides having lysophospholipase activity. | 2015-05-21 |
20150140169 | ENZYME VARIANTS - The invention relates to a polypeptide having chymosin activity which: a. is capable of hydrolysing bovine alpha s1-casein at position F23F24 so as to form αs1-I CN (f24-199) more rapidly than camel chymosin; and b. has a C/P ratio higher than the C/P ratio of bovine chymosin. | 2015-05-21 |
20150140170 | ACIDIFIED MILK PRODUCT - An acidified milk product is proposed, comprising
| 2015-05-21 |
20150140171 | TWO-PHASE FERMENTATION OF STAPHYLOCOCCUS INCREASES NITRATE REDUCTASE ACTIVITY - The present invention is related to the field of reddening of food products. In particular the present invention relates to a two-phase fermentation method for boosting the nitrate reductase activity of | 2015-05-21 |
20150140172 | SANDWICH GRANULE - The present teachings provide an improved layered granule comprising a sandwich structure of a first and second moisture barrier layer encompassing a moisture hydrating layer. The sandwich granules can be used in a variety of contexts, including animal feed. Methods of making and using are also provided. | 2015-05-21 |
20150140173 | GLUTEN-FREE FLOUR BLEND - An all-purpose gluten-free flour blend for use by persons with celiac disease, gluten sensitivity, food allergies, autism spectrum disorder, and others wishing to eliminate gluten from their diet. An embodiment of an ail-purpose gluten-free flour blend may comprise specified amounts of gluten-free whole-grain flours, other gluten-free flours, gluten-free starches, and may also include gluten-free gums and/or gluten-free vitamins and minerals. An example of this unique blend may approximate the taste, weight, texture, and performance of wheat flour. Furthermore, in an exemplary embodiment, the flour may be used as a cup for cup substitute for all-purpose wheat flour in most conventional recipes. | 2015-05-21 |
20150140174 | INFANT FORMULA MILK POWDER AND PREPARATION METHOD THEREOF - The present invention relates to an infant formula milk powder capable of preventing and alleviating infant iron deficiency anemia and a preparation method thereof. The formula milk powder comprises components such as vegetable oil, fresh milk, whey powder, lactose powder, whey protein powder, oligosaccharides, complex vitamins and complex minerals, wherein the lactoferrin and vitamin C, or alternatively, an iron source (calculated as iron), lactoferrin and vitamin C are maintained in the appropriate mass ratios, and the formula milk powder of the present invention is obtained by performing mixing, homogenizing, cooling, concentrating and spray-drying, packaging or directly using a step-by-step mixing method. The formula milk powder comprises appropriate amounts of vitamin C and lactoferrin, as well as an appropriate amount of iron source as further provided, and the three are combined according to an appropriate proportion, so that the combination of the three kinds of the substances have a synergistic effect, and the absorption and utilization rate of iron are increased dramatically, thereby not only achieving the desirable iron supplementation effect, but also preventing and alleviating the phenomenon of infant iron deficiency anemia. | 2015-05-21 |
20150140175 | HUMAN MILK PERMEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME - This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease. | 2015-05-21 |
20150140176 | Carbohydrate Gel - The present invention generally relates to the field of nutrition, in particular performance nutrition. In particular, the present invention relates to a novel carbohydrate gel comprising glucose and fructose in a ratio in the range of 3:1 to 1:1. The carbohydrate gel of the present invention can be used to treat or prevent problems with the gastrointestinal tract while allowing for an enhanced blood sugar maintenance and/or an increased exogenous carbohydrate oxidation. | 2015-05-21 |
20150140177 | SHELF-STABLE, PRESERVATIVE-FREE LIQUID BEVERAGE ENHANCER PRODUCTS - A liquid beverage enhancer product including a shelf-stable highly concentrated liquid flavor and color solution including at least 10% non-water solvents with humectant properties including propylene glycol, glycerol, ethanol and other alcohols. The liquid beverage enhancer product in combination with beverages or non-beverage food products. A method of enhancing a beverage by adding a liquid beverage enhancer product including a shelf-stable highly concentrated liquid flavor and color solution having at least 10% non-water solvents with humectant properties to a beverage, and enhancing the flavor and color of the beverage. A method of enhancing milk, milk substitute beverages, and protein containing products, by adding the liquid beverage enhancer product having a pH of greater than 4.6 to milk, milk substitute beverages, or protein containing products, and enhancing the flavor and color of the milk, milk substitute beverages, or protein containing products without curdling. | 2015-05-21 |
20150140178 | Complete Nutritional Powder and Preparation Method Thereof - The invention discloses complete nutritional powder and a preparation method thereof. The powder is characterized by containing vitamin B1, vitamin B2, vitamin B6, pantothenic acid, niacin, vitamin B 12, vitamin C, vitamin A, vitamin K, vitamin D, vitamin E, biotin, folic acid, calcium, magnesium, iron, zinc, selenium, chromium, copper, manganese, corn fiber powder, inulin, isolated soy protein powder, black bean extract, Brazil mushroom extract, soya bean lecithin, semen phaseoli extract, L-carnitine, β carotene, lycopene, citrus extract, vanadium, acerola cherry extract, grape seed extract, maltodextrin, essence, aspartame, and acesulfame. The complete nutritional powder is a specifically developed nutritional food, which is highly matched with low sugar diet and moderate exercise in a solution for treating obesity and high blood pressure, high blood sugar and high blood fat. The solution is capable of treating obesity, blood pressure, blood sugar and blood fat with excellent rehabilitation results and is suitable for wide promotion. | 2015-05-21 |
20150140179 | INFUSION PACKET AND ITS MANUFACTURE - The present invention relates to an infusion packet ( | 2015-05-21 |
20150140180 | FOOD PRODUCT AND METHOD OF MAKING SAME - An improved s'more-like food product allows the user to achieve the same taste profile as a conventional s'mores food product while greatly simplifying the preparation of the food product by the user. The improved s'more-like food product is pre-made such that the marshmallow element effectively “overwraps” the chocolate and graham cracker elements. This configuration provides a replica of a plain marshmallow, which is its aesthetic feature. That is, it looks like a traditional plain marshmallow which provides the consumer with some familiarity. However, this configuration is also functional in that it effectively eliminates mess during eating and provides a ready-to-heat product in a pre-made fashion which simplifies preparation of the s'more-like food product by the user. Edible wraps or cups can also be utilized to further enhance the eating experience and other flavors and other color variations for the food product can be provided depending on consumer preference. | 2015-05-21 |
20150140181 | COMPOSITIONS - An encapsulated flavour particle, comprising a vegetable matter particulate core and a flavour coating comprising a sprayed emulsion of flavour and thermoreversible potato starch, the thermoreversible potato starch comprising at least 80% by weight of amylopectin modified with amylomaltase enzyme. The particles provide good flavour release characteristics in consumable compositions, such as chewing gums, beverages, foodstuffs, toothpastes, mouthwashes and the like, while avoiding the use of gelatin. | 2015-05-21 |
20150140182 | INGREDIENT CAPSULE FOR BEVERAGE PREPARATION | 2015-05-21 |
20150140183 | METHOD, METERING DEVICE AND METERING VALVE FOR THE ASEPTIC MEASURED DELIVERY OF A LIQUID ADDITIVE INTO A FORCED FLOW OF A BASE PRODUCT - A method for the aseptic measured delivery of a liquid additive (Z) into a forced flow of a base product (P), wherein the additive (Z) is removed from a storage container ( | 2015-05-21 |
20150140184 | Method And Apparatus For Accelerated Or Controlled Degassing Of Roasted Coffee - An apparatus for accelerated or controlled degassing of roasted coffee. The apparatus comprises a container for receiving and retaining roasted coffee, a source of inert gas in fluid communication with the container, and a controller. The controller includes a timer and a valve. The valve is operatively associated with the source of inert gas and has an open and a closed position. When in its closed position the valve restricts the flow of inert gas into the container. When in its open position the valve permits the flow of inert gas into the container such that the inert gas displaces at least a portion of the gas in the container. The timer causes the valve to cycle between its open and closed positions at predetermined time intervals. The flow of inert gas can also be controlled through the use of a gas sensor in communication with the interior of the container. | 2015-05-21 |
20150140185 | SOLVENT-FREE APPROACH FOR SEPARATION OF CONSTITUENT FRACTIONS OF PULSES, GRAINS, OILSEEDS, AND DRIED FRUITS - The present invention relates to a novel solvent-free process for the production of protein-, starch- and fiber-enriched fractions or fractions rich in specific compounds from pulses, grains, oilseeds, and dried fruits. Unlike conventional wet processes, this dry process preserves the natural configuration and structure of separated components. This process employs a tribo-electrostatic technique to selectively charge proteins, carbohydrates, fibers, and other components in pulses, grains, oilseeds, and dried fruits and separates them based on the magnitude and type of their charge. The invention also relates to the protein-, starch-, and fiber-enriched fractions or fractions rich in specific compounds obtained using the process of this invention, and to the use of these fractions in a variety of applications that include the food industries, in particular gluten-free market, in the production of high functional protein concentrates and isolates, in particular soy protein concentrate and isolate, as pharmaceutical and/or nutraceutical agents, and in the production of bio-based materials. | 2015-05-21 |
20150140186 | CLOSTRIDIUM BOTULINUM CONTROL IN MIDLY PROCESSED REFRIGERATED FOOD PRODUCTS - The protection of low-acid, high moisture and/or high water activity processed food products against outgrowth of | 2015-05-21 |
20150140187 | Foaming Coffee Composition - The present invention provides a foaming instant coffee composition comprising particles having a bulk density of from 0.16 to 0.45 g/cm | 2015-05-21 |
20150140188 | PROCESS FOR THE CONTINUOUS PRODUCTION OF PASTEURIZED DRIED MINCED MEAT, RECONSTITUTED IN THE FORM OF THIN SLABS, AND UNIT FOR CARRYING OUT SAID PROCESS - A process for manufacturing minced meat includes
| 2015-05-21 |
20150140189 | PRODUCTS WITH IMPROVED FOAMING PROPERTIES - The present invention relates to improvements of foaming properties achieved by using unroasted coffee solids. Specifically the invention relates to dried soluble powders with improved foaming properties upon dissolution. The products have a foaming particle porosity of at least 20%. | 2015-05-21 |